Topics

[Comment] Triple therapy in a single inhaler: a new option for uncontrolled asthma

19:38 EDT 30 Sep 2019 | The Lancet

Asthma is a heterogeneous airways disease with a substantial burden.1 Although major improvements have been made in care, especially with regards to a reduction in admissions to hospital—as documented by the Global Initiative for Asthma—and asthma-related deaths, a substantial proportion of patients still have uncontrolled asthma and are prone to exacerbations.2 Because asthma patients tend to be younger adults and likely to be working, this lack of asthma control is associated with a huge economic burden and loss of quality-adjusted life-years.

Original Article: [Comment] Triple therapy in a single inhaler: a new option for uncontrolled asthma

NEXT ARTICLE

More From BioPortfolio on "[Comment] Triple therapy in a single inhaler: a new option for uncontrolled asthma"

Quick Search

Relevant Topics

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Asthma
Asthma is caused by inflammation of small tubes, called bronchi, which carry air in and out of the lungs. If you have asthma, the bronchi will be inflamed and more sensitive than normal.  When you come into contact with something that irritates your...